RSLS Live signals | Maximize Profits with Getagraph.com

BUY 115482 min ago

@ $0.190

Issued: 6 Feb 2024 @ 11:13

Return: -10.63%

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 16:00):

Stats
Today's Volume	317 524
Average Volume	496 801
Market Cap	3.98M
EPS	$-0.110 ( 2024-04-15 )
Next earnings date	( $-0.160 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0900
ATR14	$0.00200 (1.18%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-05	Schneid Yair	Sell	0	Common Stock
2023-08-04	Stankovich Thomas	Sell	108	Common Stock, $0.001 par value per share
2023-08-24	Stankovich Thomas	Sell	39	Common Stock, $0.001 par value per share
2023-09-01	Stankovich Thomas	Sell	118	Common Stock, $0.001 par value per share
2023-10-11	Stankovich Thomas	Sell	39	Common Stock, $0.001 par value per share

INSIDER POWER
-2.90
Last 95 transactions
Buy: 10 386 223 \| Sell: 2 711 639

Volume Correlation

Long: 0.22 (neutral)

Short: 0.26 (neutral)

Signal:(43.567) Neutral

ReShape Lifesciences Inc Correlation

10 Most Positive Correlations
PAIC	0.919
TLGT	0.884
SVAC	0.883
RMRM	0.881
BGFV	0.877
SPRT	0.876
AFMD	0.873
BIOC	0.873
GRNV	0.87
ALIM	0.87

10 Most Negative Correlations
NETE	-0.922
AMRB	-0.906
RAVN	-0.893
BOCH	-0.882
LSCC	-0.88
LSTR	-0.876
MMAC	-0.872
PDFS	-0.868
USLM	-0.864
RNLC	-0.863

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ReShape Lifesciences Inc Correlation - Currency/Commodity

0.08
( neutral )

-0.15
( neutral )

0.00
( neutral )

0.08
( neutral )

ReShape Lifesciences Inc Financials

Annual	2023
Revenue:	$8.68M
Gross Profit:	$5.55M (63.93 %)
EPS:	$-1.910

FY	2023
Revenue:	$8.68M
Gross Profit:	$5.55M (63.93 %)
EPS:	$-1.910

FY	2022
Revenue:	$11.24M
Gross Profit:	$6.80M (60.52 %)
EPS:	$-108.90

FY	2021
Revenue:	$13.60M
Gross Profit:	$8.35M (61.38 %)
EPS:	$-250.16

Financial Reports:

No articles found.

ReShape Lifesciences Inc

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.